Abstract
Background Whether or not a survival difference exists between radical and partial nephrectomy for stage T1 renal cell carcinoma (RCC) is controversial. We therefore aimed to evaluate cancer-specific, other cause, and overall survival among patients undergoing radical or partial nephrectomy for stage pT1 RCC.
Materials and methods We identified 330 participants with pT1a-b RCC diagnosed between 2000-2015 in three prospective cohort studies and compared treatment with radical nephrectomy (N=196) versus partial nephrectomy (N=134). The primary outcome was overall survival. Secondary outcomes were other-cause and cancer-specific mortality. Kaplan-Meier plots were used to visualize overall survival for the two treatment groups. Cox proportional hazards regression was utilized to compare outcomes between groups, and Fine and Gray competing risks regression was used to compare cancer-specific and other cause mortality between groups. Multivariable models adjusted for age, tumor size, sex, year of diagnosis, body mass index, history of smoking, history of hypertension, surgical technique, and pathological differentiation.
Results During a median follow-up of eight years, overall survival was 84%. We did not detect a statistically significant difference in overall survival between partial and radical nephrectomy (Hazard Ratio (HR) = 0.84, 95% Confidence Interval: 0.40-1.78). There was no significant difference in cause-specific or other cause mortality between groups. This study had 80% power to detect an HR ≥2.20.
Conclusions These results did not suggest a difference in long-term survival outcomes between radical and partial nephrectomy.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study relied on data from the NHS I, NHS II and HPFS, which received grant support from the National Institutes of Health (grant numbers UM1 CA186107, P01 CA87969, U01 CA176726, U01 CA 167552).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was approved by the institutional review boards of the Brigham and Women's Hospital (2005P000173/BWH) and Harvard T.H. Chan School of Public Health, and those of participating registries as required
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* Shared senior authorship
Financial support: This study relied on data from the NHS I, NHS II and HPFS, which received grant support from the National Institutes of Health (grant numbers UM1 CA186107, P01 CA87969, U01 CA176726, U01 CA 167552)
Contact: Mark A. Preston, Division of Urological Surgery, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA02115, USA. Tel: (617)525-8274 Fax: (617)525-6347 mpreston{at}bwh.harvard.edu.
The authors declare no potential conflicts of interest.
Data Availability
Data used for this analysis is not publicly available but restricted access can be discussed upon reasonable request.
